Nefertiti duPont, MD, MPH, FRCOG, FACOG
Profile
Areas of Expertise:
Cervical cancer
Endometrial cancer
High risk gynecologic cancer syndromes
Ovarian cancer
Research
Research Interests:
Improving risk stratification and surveillance of women at high risk for developing ovarian cancer
Diagnosis, treatment and management of cervical cancer
Promotion of health care education in minority communities
Robotic and minimally invasive surgery
Selected Publications:
Instituting a robot-assisted surgery programme at a tertiary care cancer centre
Mhawech-Fauceglia P, Kesterson J, Wang D, duPont NC, Akers S, Clark K, Lele S, Liu S. Expression and clinical significance of transforming growth factor β signaling pathway and its regulators in endometrial cancer. Histopathology. 2010 (in press).
duPont NC, Chandrasekhar R, Wilding G, Guru KA. Current trends in robot assisted surgery: a survey of gynecologic oncologists. International Journal of Medical Robotics and Computer Assisted Surgery. [Epub 2010 Oct 4].
duPont NC, Guru KA, Iskander GB, Odunsi K, Lele SB, Rodabaugh KJ. Instituting a robot assisted surgery program at a tertiary care cancer center. International Journal of Medical Robotics and Computer Assisted Surgery. 2010;6(3):330-333.
duPont NC, DiSaia PJ. Recurrent endometrial stromal sarcoma: treatment with a progestin and gonadotropin releasing hormone agonist. Sarcoma. [Epub 2010 June 10].
Background Information
Education and Training:
MD - Texas A & M University College of Medicine,College Station, TX
MPH - University of North Carolina at Chapel Hill, Gillings School of Global Public Health, Chapel Hill, NC
Residency:
University of Oklahoma Health Sciences Center, Oklahoma City, OK
Board Certification:
Obstetrics and Gynecology, American Board of Obstetrics and Gynecology
Fellowships:
University of California at Irvine, Orange, CA
